Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) PT at $9.94

Shares of Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) have earned a consensus recommendation of "Hold" from the eleven brokerages that are covering the stock, Marketbeat.com reports. Nine investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $9.94.

Several equities analysts recently commented on DH shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a research note on Wednesday, May 8th. Barclays decreased their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an "equal weight" rating on the stock in a report on Thursday, May 9th. Morgan Stanley downgraded Definitive Healthcare from an "overweight" rating to an "equal weight" rating and lowered their price objective for the stock from $11.50 to $9.00 in a research report on Wednesday, May 8th. Stifel Nicolaus reduced their target price on Definitive Healthcare from $11.00 to $9.50 and set a "buy" rating for the company in a research report on Wednesday, May 8th. Finally, William Blair reaffirmed an "outperform" rating on shares of Definitive Healthcare in a report on Tuesday.

Institutional Trading of Definitive Healthcare

Several institutional investors have recently bought and sold shares of DH. Arizona State Retirement System increased its holdings in shares of Definitive Healthcare by 13.6% in the 4th quarter. Arizona State Retirement System now owns 14,253 shares of the company's stock worth $142,000 after purchasing an additional 1,701 shares in the last quarter. OLD National Bancorp IN raised its position in Definitive Healthcare by 14.5% in the 3rd quarter. OLD National Bancorp IN now owns 20,613 shares of the company's stock worth $165,000 after buying an additional 2,609 shares during the last quarter. Corton Capital Inc. lifted its stake in Definitive Healthcare by 17.0% during the 3rd quarter. Corton Capital Inc. now owns 19,964 shares of the company's stock valued at $160,000 after acquiring an additional 2,898 shares during the period. Swiss National Bank boosted its holdings in shares of Definitive Healthcare by 2.9% during the 1st quarter. Swiss National Bank now owns 103,300 shares of the company's stock valued at $834,000 after acquiring an additional 2,900 shares during the last quarter. Finally, Wrapmanager Inc. grew its stake in shares of Definitive Healthcare by 10.8% in the third quarter. Wrapmanager Inc. now owns 36,501 shares of the company's stock worth $292,000 after acquiring an additional 3,563 shares during the period. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Price Performance

Definitive Healthcare stock remained flat at $5.50 during trading on Friday. The company had a trading volume of 690,582 shares, compared to its average volume of 1,116,758. The company's 50-day moving average price is $7.24 and its 200 day moving average price is $8.24. Definitive Healthcare has a fifty-two week low of $4.38 and a fifty-two week high of $12.45. The firm has a market cap of $648.62 million, a PE ratio of -3.14, a price-to-earnings-growth ratio of 4.74 and a beta of 1.41. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.30 and a current ratio of 2.30.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by ($0.02). The firm had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. As a group, equities research analysts anticipate that Definitive Healthcare will post 0.1 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.